Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VIAGENEX
- Development stage
- Discontinued
- Lead developer
- Vivex Biologics
- Modality
- Cell Therapies
- Administration
- Surgical Implantation
01
Overview
VIAGENEX is a viable allogeneic bone matrix (VABM) developed by VIVEX Biologics, designed for use in orthopedic and spinal fusion procedures. Regulated as a Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) under Section 361 of the PHS Act, it is processed to preserve the native bone's regenerative components. The product provides a triad of bone-healing properties: an osteoconductive scaffold (mineralized and demineralized bone), osteoinductive potential (endogenous growth factors like Bone Morphogenetic Proteins), and osteogenic viable cells (including mesenchymal stem cells and osteoprogenitors). It is typically supplied as a cryopreserved graft that is thawed immediately before surgical implantation to ensure high cell viability and optimal clinical outcomes in promoting bone formation and fusion.
- Brand names
- VIAGENEX
- Other names
- Viable Allogeneic Bone MatrixTissue allograft
Beyond the preview
Go deeper on VIAGENEX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VIAGENEX.